Plain-English translation of NCT07089303 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This is a research study that follows 750 people over at least four years to find early warning signs of Alzheimer's disease using advanced brain imaging technology. Researchers will take detailed brain scans, collect blood samples, and perform memory tests to understand how the brain changes before and during Alzheimer's disease. The goal is to create a database that helps doctors detect Alzheimer's earlier, when treatments might be most helpful.
Alzheimer's disease damages the brain long before symptoms appear, but doctors don't yet have reliable ways to catch it early. This study aims to find brain changes and blood markers that could help identify people at risk for Alzheimer's before memory loss becomes severe, potentially opening doors to earlier treatment.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital for a baseline visit where you'll have a detailed brain scan using a specialized 7-Tesla MRI machine, memory and thinking tests, and a blood draw. You'll then return for follow-up visits over at least four years to repeat these tests and scans, allowing researchers to track how your brain changes over time. The study is designed to follow you for years, so commitment to returning for regular visits is important.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China
Sponsor
Chinese PLA General Hospital
Enrollment target
~750 participants
Started
July 2025
Primary completion
July 2029
Age range
55 Years – 90 Years
Last updated on clinicaltrials.gov in August 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.